Zuellig Pharma Establishes New Logistics Hub in Misato, Saitama, to Strengthen Clinical Logistics and Sourcing Capabilities in Japan

Zuellig Pharma (Headquarters: Singapore; CEO: John Graham) has announced the relocation and opening of a new logistics hub for clinical trials in Misato City, Saitama Prefecture, Japan. Through this new facility, the company will realize clinical operations with greater agility while maintaining global quality standards, further strengthening its system for supporting pharmaceutical clinical trials in Japan.

Japan remains highly regarded as one of the preferred hubs for clinical research in the Asia-Pacific region due to its strong focus on medical advancements, strict ethical standards, and commitment to medical development. As medical innovation continues to accelerate across the Asia-Pacific region, countries including China, India, Australia, Japan, South Korea, Taiwan, and Singapore have emerged over the last five years as key pillars supporting the clinical trial ecosystem (Note 1). In this environment, the relocation of the logistics hub to Misato demonstrates Zuellig Pharma's commitment to continuously providing sponsors and clients with reliable, compliant, and consistent market access.

The new Misato facility consolidates the knowledge, best-in-class operating methods, and expertise in clinical logistics and sourcing that Zuellig Pharma has accumulated over many years. With an experienced and specialized Japanese team, the facility provides precise project management tailored to Japan's complex regulatory and logistics requirements, even as the clinical landscape continues to evolve.

David Christmas, Senior Vice President of Logistics & Clinical Trial Support at Zuellig Pharma, stated, "Japan is a critical market for clinical research. With this hub relocation and opening, we have established a system to reliably provide the speed, compliance, and operational management that sponsors require. Together with our local team of experts, we will continue to provide high-quality clinical logistics and sourcing services. Furthermore, in Japan, which is one of the world's leading pharmaceutical markets and the second-largest brand-name drug market globally (Note 2), we will support our sponsors and clients in mitigating risks."

The Misato logistics hub offers efficient, all-in-one solutions for global sponsors aiming for rapid, compliant entry into the Japanese market. By leveraging Zuellig Pharma's strategically deployed network of clinical hubs, sponsors can benefit from the same level of operational excellence, regulatory compliance, and service consistency while reducing the burden of building and operating large, dedicated, in-house facilities.

The relocation of the Misato logistics hub is part of Zuellig Pharma's ongoing efforts to accelerate clinical development across the Asia-Pacific region and improve patient access to innovative treatments. Through such strategic developments, Zuellig Pharma will further strengthen its position as a partner for global clinical development in the Asia-Pacific region. Moving forward, the company will continue to provide high-quality, compliant clinical logistics and sourcing solutions by combining scale, expertise, and agility across the entire Asia-Pacific region.

Note 1: https://www.biospectrumasia.com/analysis/25/26280/medical-advances-soar-with-apacs-clinical-trial-growth.html

Note 2: https://www.clinicaltrialsarena.com/news/japan-offers-competitive-edge-with-clinical-trial-landscape-and-smo-approach/

About Zuellig Pharma

Zuellig Pharma is a leading healthcare solutions company in Asia, with the goal of bringing better healthcare access to the communities it serves. The company provides world-class pharmaceutical logistics, commercialization, and clinical trial support services, constantly innovating to meet the healthcare needs of the growing Asian region. Since its founding in 1922, the company has expanded its operations and has grown into a multi-billion dollar business with over 12,000 employees across 18 markets today. Zuellig Pharma's employees support over 200,000 medical institutions in Asia and partner with over 450 pharmaceutical companies, including the world's top 20. For more information, please visit https://www.zuelligpharma.com/.

Overview of Zuellig Pharma Misato Logistics Hub

Address: Shin-Misato LaLa City 3-3-1, Misato City, Saitama Prefecture

Misato No. 1 Distribution Center, Building A, 1st and 2nd Floors

Person in Charge: Shota Taki, Quality Manager

STaki@zuelligpharma.com